Panitumumab Biosimilar - Research Grade

Human

EGFR

1.0 - 5.0 mg/ml

Human IgG2 kappa

Humanized

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.

Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Detects human EGFR. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Panitumumab.

Blue ice

A receptor tyrosine kinase that fuels proliferative signalling in many epithelial tumours, the epidermal growth factor receptor (EGFR) is a major research target. This research-grade anti-human EGFR recombinant monoclonal antibody is an unconjugated, non-therapeutic analog of panitumumab, built around the EGFR target as a human IgG2-kappa for research use only. Manufactured to in vivo standards as an ultra-pure, low-endotoxin preparation, it is supplied in scalable milligram to gram quantities for high-throughput and bulk laboratories. It supports preclinical work including EGFR-blocking assays, in vitro screening, in vivo tumour models, and antibody-drug conjugate development.

Epidermal growth factor receptor, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1, ERBB, ERBB1, HER1

P00533

ICH3001-100ml ICH3002-100ml ICH3003-100ml

https://www.imgt.org/mAb-DB/